Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

Clinical trial NCT07181785 · COMPLETED

Trial details

NCT number: NCT07181785
Sponsor: Andrés José Maria Ferreri
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2022-07-12
Primary completion: 2023-07-12
Enrollment: 555

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.